CIK 0001664710
- Non-accelerated filer
- Smaller reporting company
Keros Therapeutics, Inc.
Sign in to watch- Ticker
- KROS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- Operating
- EIN
- 811173868
- Phone
- +1 617-314-6297
- Business address
- 1050 WALTHAM STREET, SUITE 302, LEXINGTON, MA, 02421
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,619
- in 1 filing, $6K under 10b5-1 plans
Net −$5,619. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-03-02 | Knowles Julius Director | Sale | −686 | $60.05 | $41K | 430,734 |
| 2021-03-02 | Knowles Julius Director | Sale | −554 | $60.61 | $34K | 644,626 |
| 2021-03-02 | Knowles Julius Director | Sale | −361 | $60.61 | $22K | 430,373 |
| 2021-03-02 | Knowles Julius Director | Sale | −138 | $61.90 | $9K | 644,488 |
| 2021-03-02 | Knowles Julius Director | Sale | −90 | $61.90 | $6K | 430,283 |
| 2021-03-01 | Knowles Julius Director | Sale | −1,608 | $61.33 | $99K | 657,219 |
| 2021-03-01 | Knowles Julius Director | Sale | −1,050 | $61.33 | $64K | 438,584 |
| 2021-03-01 | Knowles Julius Director | Sale | −2,257 | $62.11 | $140K | 654,962 |
| 2021-03-01 | Knowles Julius Director | Sale | −1,473 | $62.11 | $91K | 437,111 |
| 2021-03-01 | Knowles Julius Director | Sale | −1,794 | $63.22 | $113K | 653,168 |
| 2021-03-01 | Knowles Julius Director | Sale | −1,169 | $63.22 | $74K | 435,942 |
| 2021-03-01 | Knowles Julius Director | Sale | −625 | $64.09 | $40K | 652,543 |
| 2021-03-01 | Knowles Julius Director | Sale | −406 | $64.09 | $26K | 435,536 |
| 2021-03-01 | Knowles Julius Director | Sale | −734 | $65.29 | $48K | 651,809 |
| 2021-03-01 | Knowles Julius Director | Sale | −479 | $65.28 | $31K | 435,057 |
| 2021-03-01 | Knowles Julius Director | Sale | −792 | $66.04 | $52K | 651,017 |
| 2021-03-01 | Knowles Julius Director | Sale | −516 | $66.04 | $34K | 434,541 |
| 2021-03-01 | Knowles Julius Director | Sale | −46 | $67.60 | $3K | 650,971 |
| 2021-03-01 | Knowles Julius Director | Sale | −30 | $67.60 | $2K | 434,511 |
| 2021-02-26 | Lachey Jennifer Chief Scientific Officer | Exercise or conversion | +33,200 | $0.11 | $4K | 61,191 |
Page 25 of 36 · 707 trades